The theme: The GLP-1 complex — the large-cap manufacturers shipping today and the clinical-stage challengers behind them. Spans big pharma and biotech, so the scores span two very different risk profiles.
How this ranking works
Weight-Loss Drugs isn't a standard sector — its companies are scattered across different industries, so no off-the-shelf classification groups them. This is a curated list of Weight-Loss Drugs pure-plays in our US universe, each scored on the same transparent quality-growth model — one 0–100 score blending business quality (margins and returns on capital), growth (revenue and earnings), and value (what you pay for them). The table ranks them by that score, highest first, and re-scores every trading day. Click any name for the full grade card, price targets, and analysis.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.